News & Events

Leica Biosystems is pleased to announce the launch of two new primary antibodies, PD-L1 and HER2, developed to support cancer research and therapy development. These antibodies, widely used in studying breast, lung, and other cancers, underscore our commitment to empowering pharmaceutical partners…

January 28, 2025 – Nussloch, Germany. Leica Biosystems, a global leader in anatomic pathology, is known for its high-quality histology solutions. Today, the company announced the next iteration in its staining and coverslipping portfolio, the HistoCore CHROMAX Workstation (WS). Today, many…

Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology, today announced a partnership to enable fully integrated RNA-ISH using the BOND RX and BOND RXm research staining systems. …

January 17, 2025 - VISTA, CA – Building on 25 years of leading innovation, we are excited to unveil the latest groundbreaking advancements for our Aperio GT 450 Digital Pathology Scanner The Aperio GT 450 scanner’s proven technology, renowned for performance and reliability, is taken to the next…

The facility will begin developing antibody-drug-conjugates to enhance personalized cancer treatment. NEWCASTLE UPON TYNE, January 16, 2025 – Leica Biosystems, a global leader in anatomic pathology, has received a Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-…

Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicine paradigm, from early biomarker discovery to clinical trials, and through to routine diagnostics. Vista, CA, and Albuquerque, NM, January 8, 2025 –…

December 4, 2024, Nussloch, Germany. - Leica Biosystems has announced a new printing solution to optimize laboratory workflow using laser technology. The HistoCore LIGHTNING S is an on-demand and batch laser printer optimized for use with Leica Biosystems’ staining solutions. The laser etching…

Fully automated SignalStar™ Multiplex IHC protocol on the BOND RX by Leica Biosystems eliminates hands-on time for streamlined image generation and analysis in two days Melbourne, Australia , November 4, 2024 – Leica Biosystems is pleased to announce a collaboration with Cell Signaling…

VISTA, CA – 01 November 2024 - Leica Biosystems, a global leader in anatomic pathology, today announced non-enforcement of their Digital Pathology DICOM (Digital Imaging and Communications in Medicine) patent portfolio, to accelerate the usage of DICOM and standardization in Digital Pathology.…

As a new partner of the Asian Society of Digital Pathology, Leica Biosystems now supports all three continental digital pathology societies. Seoul, South Korea – Leica Biosystems has announced its diamond partnership with the Asian Society of Digital Pathology (ASDP), making the company a sponsor…